BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 19147304)

  • 1. Risk of hypogonadism from scatter radiation during pelvic radiation in male patients with rectal cancer.
    Yau I; Vuong T; Garant A; Ducruet T; Doran P; Faria S; Liberman S; Richard C; Letellier F; Charlebois P; Loungnarath R; Stein B; Devic S
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1481-6. PubMed ID: 19147304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in hormone levels after adjuvant chemoradiation in male rectal cancer patients.
    Yoon FH; Perera F; Fisher B; Stitt L
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1186-90. PubMed ID: 19095371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testicular dose and hormonal changes after radiotherapy of rectal cancer.
    Hermann RM; Henkel K; Christiansen H; Vorwerk H; Hille A; Hess CF; Schmidberger H
    Radiother Oncol; 2005 Apr; 75(1):83-8. PubMed ID: 15878105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotherapy for rectal cancer is associated with reduced serum testosterone and increased FSH and LH.
    Bruheim K; Svartberg J; Carlsen E; Dueland S; Haug E; Skovlund E; Tveit KM; Guren MG
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):722-7. PubMed ID: 18262088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose-rate interstitial brachytherapy in recurrent and previously irradiated head and neck cancers--preliminary results.
    Narayana A; Cohen GN; Zaider M; Chan K; Lee N; Wong RJ; Boyle J; Shaha A; Kraus D; Shah J; Zelefsky MJ
    Brachytherapy; 2007; 6(2):157-63. PubMed ID: 17434110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The safety and usefulness of high-dose-rate endoluminal brachytherapy as a boost in the treatment of patients with esophageal cancer with external beam radiation with or without chemotherapy.
    Vuong T; Szego P; David M; Evans M; Parent J; Mayrand S; Corns R; Burtin P; Faria S; Devic S
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):758-64. PubMed ID: 16199311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetric parameters that predict late rectal complications after curative radiotherapy in patients with uterine cervical carcinoma.
    Hyun Kim T; Choi J; Park SY; Lee SH; Lee KC; Yang DS; Shin KH; Cho KH; Lim HS; Kim JY
    Cancer; 2005 Sep; 104(6):1304-11. PubMed ID: 16078262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testosterone production is better preserved after 16 than 20 Gray irradiation treatment against testicular carcinoma in situ cells.
    Bang AK; Petersen JH; Petersen PM; Andersson AM; Daugaard G; Jørgensen N
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):672-6. PubMed ID: 19250763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of severe gastrointestinal toxicity after external beam radiotherapy and interstitial brachytherapy for advanced or recurrent gynecologic malignancies.
    Kasibhatla M; Clough RW; Montana GS; Oleson JR; Light K; Steffey BA; Jones EL
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):398-403. PubMed ID: 16542793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rectal morbidity following I-125 prostate brachytherapy in relation to dosimetry.
    Ohashi T; Yorozu A; Toya K; Saito S; Momma T; Nagata H; Kosugi M
    Jpn J Clin Oncol; 2007 Feb; 37(2):121-6. PubMed ID: 17255159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal predictors of prostate cancer.
    Sofikerim M; Eskicorapci S; Oruç O; Ozen H
    Urol Int; 2007; 79(1):13-8. PubMed ID: 17627161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation in rectal cancer between clinical tumor response after neoadjuvant radiotherapy and sphincter or organ preservation: 10-year results of the Lyon R 96-02 randomized trial.
    Ortholan C; Romestaing P; Chapet O; Gerard JP
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e165-71. PubMed ID: 22579379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric factors predicting severe radiation-induced bowel complications in patients with cervical cancer: combined effect of external parametrial dose and cumulative rectal dose.
    Huang EY; Wang CJ; Hsu HC; Hao Lin ; Chen HC; Sun LM
    Gynecol Oncol; 2004 Oct; 95(1):101-8. PubMed ID: 15385117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rectal bleeding after high-dose-rate brachytherapy combined with hypofractionated external-beam radiotherapy for localized prostate cancer: impact of rectal dose in high-dose-rate brachytherapy on occurrence of grade 2 or worse rectal bleeding.
    Akimoto T; Katoh H; Kitamoto Y; Tamaki T; Harada K; Shirai K; Nakano T
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):364-70. PubMed ID: 16690428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiochemotherapy in combination with regional hyperthermia in preirradiated patients with recurrent rectal cancer.
    Milani V; Pazos M; Issels RD; Buecklein V; Rahman S; Tschoep K; Schaffer P; Wilkowski R; Duehmke E; Schaffer M
    Strahlenther Onkol; 2008 Mar; 184(3):163-8. PubMed ID: 18330513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High dose rate brachytherapy as a boost after preoperative chemoradiotherapy for more advanced rectal tumours: the Clatterbridge experience.
    Sun Myint A; Lee CD; Snee AJ; Perkins K; Jelley FE; Wong H
    Clin Oncol (R Coll Radiol); 2007 Nov; 19(9):711-9. PubMed ID: 17884396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Follow-up study of clinical effects of californium-252 neutron intracavitary radiotherapy and external beam radiotherapy in endometrial cancer].
    Lei X; Shan JL; Tang C; Zhao KW
    Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):733-6. PubMed ID: 18307897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Phase II study of high-dose-rate afterloading brachytherapy as monotherapy for the treatment of localized prostate cancer.
    Corner C; Rojas AM; Bryant L; Ostler P; Hoskin P
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):441-6. PubMed ID: 18249501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High dose rate afterloading intraluminal brachytherapy for advanced inoperable rectal carcinoma.
    Hoskin PJ; de Canha SM; Bownes P; Bryant L; Glynne Jones R
    Radiother Oncol; 2004 Nov; 73(2):195-8. PubMed ID: 15542167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
    Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
    Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.